Latest filing published 15 Nov 2017 for Apellis Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Hillhouse Capital Management, Ltd.: trading record in brief
Hillhouse Capital Management, Ltd. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Apellis Pharmaceuticals, Inc. and BeOne Medicines Ltd. In total, 4 filings cover trades dated from 8 February 2016 to 13 November 2017.
No open-market sale appears; the market trades are 2 purchases worth €17.2M. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2017, the count stands at 1 purchase and no sales.
The record was last updated on 15 November 2017 with a transaction in Apellis Pharmaceuticals, Inc. The most recent open-market purchase was published on 15 November 2017, 3,281 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Hillhouse Capital Management, Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,098,581 sharesCommon StockSEC:0000902664-17-004362:0
- 1,428,571 shares@ US$14.00100.0% of flowCommon StockSEC:0000902664-17-004362:1Canonical exit: 11 Feb 2018 (T+90)
- 30,626,779 sharesOrdinary SharesSEC:0000902664-16-005447:0
- 9,100,000 sharesOrdinary SharesSEC:0000902664-16-005447:1Canonical exit: 8 May 2016 (T+90)
4 of 4 declarations
